We were interested to examine the mechanism of anti-cancer drug-resistance conferred by CAGE.We present evidence that CAGE confers anti-cancer drug-resistance by binding to GSK3β and increasing the expression of cyclin D1 and pGSK3βSer9. The gene discussed is GSK3B; the disease is cancer.